Elanco CFO buys 4,200 shares and receives DSUs

Elanco Animal Health EVP and CFO Robert M. VanHimbergen reported two transactions on August 7, 2026.

Rhea-AI Filing Summary

Elanco Animal Health EVP and CFO Robert M. VanHimbergen reported two transactions on August 7, 2026. He received a grant of 8.9069 Deferred Stock Units, each representing the right to one share of common stock or cash, bringing his Deferred Stock Unit balance to 133.6048. On the same date, he purchased 4,200 shares of common stock in multiple transactions at a weighted average price of $23.0776 per share, with individual prices ranging from $23.01 to $23.09. Following these purchases, he directly owns 137,516 shares of Elanco Animal Health common stock.

Insider Trade Summary

Net Buyer: 4,200 shares

Net Buy 2 txns

Insider VanHimbergen Robert M

Role EVP and CFO

Bought 4,200 shs ($97K)

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units F2, F3	8.9069	$22.12	$197.02
Purchase	Common Stock F1	4,200	$23.0776	$97K

Holdings After Transaction: Deferred Stock Units — 133.6048 contracts (Direct); Common Stock — 137,516 shares (Direct)

Footnotes (3)

1. F1. Reflects the weighted average price of 4,200 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 7, 2026 with purchase prices ranging from $23.01 to $23.09 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
2. F2. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
3. F3. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Common shares purchased: 4,200 shares Weighted average purchase price: $23.0776 per share Common shares held after transaction: 137,516 shares +2 more

5 metrics

Common shares purchased 4,200 shares Open-market purchases on August 7, 2026 by EVP and CFO

Weighted average purchase price $23.0776 per share Multiple trades between $23.01 and $23.09 on August 7, 2026

Common shares held after transaction 137,516 shares Direct ownership after August 7, 2026 purchases

Deferred Stock Units granted 8.9069 units Grant of Deferred Stock Units on August 7, 2026

Deferred Stock Units balance 133.6048 units Deferred Stock Units directly held after grant

Key Terms

Deferred Stock Units, weighted average price, Executive Deferral and Stock Match Plan

3 terms

Deferred Stock Units financial

"Each deferred stock unit represents the right to receive one share of Company common stock"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

weighted average price financial

"Reflects the weighted average price of 4,200 shares of common stock"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Executive Deferral and Stock Match Plan financial

"in accordance with Executive Deferral and Stock Match Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Elanco Animal Health (ELAN) report for Robert M. VanHimbergen?

Elanco Animal Health reported that EVP and CFO Robert M. VanHimbergen received 8.9069 Deferred Stock Units and purchased 4,200 shares of common stock on August 7, 2026, in open-market transactions.

How many Elanco (ELAN) shares did the CFO buy and at what price?

The CFO purchased 4,200 shares of Elanco common stock at a weighted average price of $23.0776 per share, with individual trades executed between $23.01 and $23.09 on August 7, 2026.

What are the CFO’s Elanco (ELAN) common stock holdings after these transactions?

After the reported purchases, Robert M. VanHimbergen directly holds 137,516 shares of Elanco Animal Health common stock, according to the Form 4 reporting his August 7, 2026 transactions.

What Deferred Stock Units did the Elanco (ELAN) CFO receive?

He received 8.9069 Deferred Stock Units, each representing the right to receive one share of common stock or the cash equivalent, increasing his Deferred Stock Unit balance to 133.6048 units.

When will the Elanco (ELAN) Deferred Stock Units for the CFO settle?

The Deferred Stock Units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, under the Executive Deferral and Stock Match Plan.

Were the Elanco (ELAN) CFO’s share purchases made in a single trade or multiple trades?

The CFO’s purchase of 4,200 shares was executed in multiple transactions on August 7, 2026, at prices ranging from $23.01 to $23.09 per share, reported as a weighted average.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/10/2026 - 04:14 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VanHimbergen Robert M

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/07/2026		P		4,200	A	$23.0776(1)	137,516	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(2)	08/07/2026		A		8.9069		(3)	(3)	Common Stock	8.9069	$22.12	133.6048	D

Explanation of Responses:

1. Reflects the weighted average price of 4,200 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 7, 2026 with purchase prices ranging from $23.01 to $23.09 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

2. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

3. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)